TOP2A and leukemia: Together, these results demonstrate that CRISPR/Cas9/HDR editing of the TOP2α gene to abrogate normal RNA processing results in etoposide resistance in human leukemia K562 cells and further supports the dual role of TOP2α/170 and TOP2α/90 isoforms as sensitivity/resistance determinants.